In addition to applying genome-wide significance thresholds, future MR studies investigating the relationships between AD/PD and cancers could adopt biologically informed strategies, such as selecting SNPs located within key cancer-related genes (e.g., TP53, RB1, BRCA1/2, PIN1) or relevant functional pathways. This evidence concerns the gene RB1 and Parkinson disease.